Neurotoxicity of acetaldehyde-derived advanced glycation end products for cultured cortical neurons

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 5, 2003, Pages 486-496

  Takeuchi, Masayoshi ^a   Watai, Takayuki ^a   Sasaki, Nobuyuki ^b   Choei, Hiroshi ^b   Iwaki, Mina ^a   Ashizawa, Takeshi ^c   Inagaki, Yosuke ^d   Yamagishi, Sho Ichi ^d   Kikuchi, Seiji ^e   Riederer, Peter ^f   Saito, Toshikazu ^b   Bucala, Richard ^g   Kameda, Yukihiko ^a  

^a HOKURIKU UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c Asahiyama Hospital   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetaldehyde; Acetaldehyde derived advanced glycation end products (AA AGEs); Advanced glycation end products (AGEs); Alcoholism; Neurotoxicity

Indexed keywords

ACETALDEHYDE; ALCOHOL; ANTIBODY; BRAIN PROTEIN; EPITOPE;

AGING; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIABETIC ANGIOPATHY; EMBRYO; GLYCATION; HYPOTHESIS; IN VIVO STUDY; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0037651940     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.5.486     Document Type: Article

References (36)

1. Hunt WA. Role of acetaldehyde in the actions of ethanol on the brain - A review. Alcohol 1996;13:147-51
2. Eriksson CJP. The role of acetaldehyde in the actions of alcohol (Update 2000). Alcohol Clin Exp Res 2001;25:15S-32S
3. Bucala R, Cerami A. Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging. Adv Pharmcol 1992;23: 1-34
4. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994;70:138-51
5. Brownlee M. Advanced protein glycosylation in diabetes and aging. Ann Rev Med 1995;46:223-34
6. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997;46:S19-S25
7. Vitek MP, Bhattacharya K, Glendening JM, et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 1994;91:4766-70
8. Smith MA, Taneda S, Richey PL, et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 1994;91:5710-14
9. Yan SD, Chen X, Schmidt AM, et al. Glycated tau protein in Alzheimer disease: A mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 1994;91:7787-91
10. Sasaki N, Fukatsu R, Tsuzuki K, et al. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol 1998;153:1149-55
11. Sasaki N, Toki S, Choei H, et al. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res 2001;888:256-62
12. Castellani R, Smith MA, Richey PJ, Petty G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 1996;737:195-200
13. Sasaki N, Takeuchi M, Choei H, et al. Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques. Neurosci Lett 2002;326:117-20
14. Kikuchi S, Shinpo K, Ogata A, et al. Detection of N-(carboxymethyl)lysine (CML) and non-CML advanced glycation end products in the anterior horn of amyotrophic lateral sclerosis spinal cord. Amyotroph Lateral Scler Other Motor Neuron Disord 2002;3: 63-68
15. Chou SM, Wang HS, Taniguchi A, Bucala R. Advanced glycation end products in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis. Mol Med 1998; 4:324-32
16. Al-Abed Y, Kapurniotu A, Bucala R. Advanced glycation end products: Detection and reversal. Methods Enzymol 1999;309:152-71
17. Takeuchi M, Makita Z, Yanagisawa K, Kameda Y, Koike T. Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients. Mol Med 1999;5:393-405
18. Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T, Kameda Y. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol Med 2000;6:114-25
19. Takeuchi M, Yanase Y, Matsuura N, et al. Immunological detection of a novel advanced glycation end-product. Mol Med 2001;7:783-91
20. Takeuchi M, Makita Z. Alternative routes for the formation of immunochemically distinct advanced glycation end-products in vivo. Curr Mol Med 2001;1:305-15
21. Koga K, Yamagishi S, Okamoto T, et al. Serum levels of glucosederived advanced glycation end products are associated with the severity of diabetic retinopathy in type 2 diabetic patients without renal dysfunction. Int J Clin Pharm Res 2002;22:23-27
22. Miura J, Yamagishi S, Uchigata Y, et al. Serum leveles of noncarboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with type 1 diabetes. J Diabetes Complicat 2003;17:16-21
23. Yamagishi S, Amano S, Inagaki Y, et al. Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes. Biochem Biophys Res Commun 2002;290:973-78
24. Yamagishi S, Inagaki Y, Okamoto T et al. Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-I in human cultured mesangial cells. J Biol Chem 2002;277:20309-15
25. Takeuchi M, Bucala R, Suzuki T, et al. Neurotoxicity of advanced glycation end-products for cultured cortical neurons. J Neuropathol Exp Neurol 2000;59:1094-1105
26. Thiele GM, Tuma DJ, Miller JA, Wegter KM, McDonald TL, Klassen LW. Monoclonal and polyclonal antibodies recognizing acetaldehyde-protein adducts. Biochem Pharmacol 1998;56:1515-23
27. Ikeda K, Higashi T, Sano H, et al. N-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996;35:8075-83
28. Ahmed MU, Frye EB, Degenhardt TP, Thorpe SR, Baynes JW. N-(Carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997;324:565-70
29. 2+ after exposure to glutamate receptor agonist. Exp Brain Res 1988;73:447-58
30. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Immunol Methods 1983;65:55-63
31. Gsell W, Lange KW, Pfeuffer R, et al. How to run a brain bank. A report from the Austro-German brain bank. J Neural Transm 1993; 39:31-70
32. Al-Abed Y, Mitsuhashi T, Li H, et al. Inhibition of advanced glycation endproduct formation by acetaldehyde: Role in the cardioprotective effect of ethanol. Proc Natl Acad Sci USA 1999;96: 2385-90
33. Jeong KS, Soh Y. Jeng J, Felder MR, Hardwick JP, Song BJ. Cytochrome P450 2E1 (CYP2E 1)-dependent production of a 37-kDa acetaldehyde-protein adduct in the rat liver. Arch Biochem Biophys 2000;384:81-87
34. Nakamura K, Iwahashi K, Itoh M, et al. Immunohistochemical study on acetaldehyde adducts in alcohol-fed mice. Alcohol Clin Exp Res 2000;24:93S-96S
35. Rintala J, Jaatinen P, Parkkila S, et al. Evidence of acetaldehydeprotein adduct formation in rat brain after lifelong consumption of ethanol. Alcohol Alcohol 2000;35:458-63
36. Upadhya SC, Ravindranath V Detection and localization of proteinacetaldehyde adducts in rat brain after chronic ethanol treatment. Alcohol Clin Exp Res 2002;26:856-63